SHORT-TERM DUAL ANTIPLATELET THERAPY REDUCES BLEEDING RISK WITHOUT INCREASING ISCHEMIC RISK IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION WITH THIRD-GENERATION DRUG-ELUTING STENTS: A POST HOC ANALYSIS OF THE HOST-IDEA TRIAL

被引：0
|
作者：
Han, Jung-kyu [1 ]
Lee, Keehwan [1 ]
Park, Sang-Hyeon [1 ]
Yang, Seokhun [1 ]
Hwang, Doyeon [1 ]
Kang, Jeehoon [1 ]
Yang, Han-Mo [1 ]
Park, Kyung Woo [1 ]
Kang, Hyun-Jae [1 ]
Koo, Bon Kwon [1 ]
Kim, Hyo-Soo [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1042-05
引用
收藏
页码：1160 / 1160
页数：1
相关论文
共 31 条
  • [21] Drug-eluting stents compared to bare-metal stents improve short-term survival in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a nationwide prospective analysis of the AMIS Plus registry
    Jaguszewski, Milosz
    Radovanovic, Dragana
    Nallamothu, Brahmajee K.
    Urban, Philip
    Erne, Paul
    KARDIOLOGIA POLSKA, 2014, 72 (04) : 315 - 323
  • [22] Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention Results From a Propensity Score-Matched Analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry
    Bangalore, Sripal
    Cohen, David J.
    Kleiman, Neal S.
    Regev-Beinart, Tal
    Rao, Sunil V.
    Pencina, Michael J.
    Mauri, Laura
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (05) : 463 - 473
  • [23] Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention results from a propensity score-matched analysis of the evaluation of drug-eluting stents and ischemic events (EVENT) registry
    South China Journal of Cardiology, 2011, (04) : 271 - 272
  • [24] A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial
    Zwart, Bastiaan
    Bor, Willem Lambertus
    de Veer, Anne Johanna Wilhelmina Maria
    Mahmoodi, Bakhtawar Khan
    Kelder, Johannes Christiaan
    Lip, Gregory Y. H.
    Bhatt, Deepak L.
    Cannon, Christopher P.
    ten Berg, Jurrien Maria
    EUROINTERVENTION, 2022, 18 (04) : E292 - +
  • [25] Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherarpy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
    Giacoppo, Daniele
    Matsuda, Yuji
    Fovino, Luca Nai
    D'Amico, Gianpiero
    Gargiulo, Giuseppe
    Byrne, Robert A.
    Capodanno, Davide
    Valgimigli, Marco
    Mehran, Roxana
    Tarantini, Giuseppe
    EUROPEAN HEART JOURNAL, 2021, 42 (04) : 308 - 319A
  • [26] Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention? "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)
    Kirtane, Ajay J.
    Parikh, Puja B.
    Stuckey, Thomas D.
    Xu, Ke
    Witzenbichler, Bernhard
    Weisz, Giora
    Rinaldi, Michael J.
    Neumann, Franz-Josef
    Metzger, D. Christopher
    Henry, Timothy D.
    Cox, David A.
    Duffy, Peter L.
    Brodie, Bruce R.
    Mazzaferri, Ernest L., Jr.
    Parvataneni, Rupa
    Maehara, Akiko
    Genereux, Philippe
    Mehran, Roxana
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (15) : 1978 - 1987
  • [27] Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents - A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials
    Wassef, Anthony W. A.
    Khafaji, Hadi
    Syed, Ishba
    Yan, Andrew T.
    Udell, Jacob A.
    Goodman, Shaun G.
    Cheema, Asim N.
    Bagai, Akshay
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (12): : E203 - E210
  • [28] Comparison of biodegradable and newer generation durable polymer drug-eluting stents with short-term dual antiplatelet therapy: a systematic review and Bayesian network meta-analysis of randomized trials comprising of 43,875 patients
    Bryan Chong
    Rachel Sze Jen Goh
    Gwyneth Kong
    Faith Ruo En Sim
    Chen Han Ng
    Xin Yi Vanessa Teo
    Jing Xuan Quek
    Oliver Lim
    Yip Han Chin
    Siew-Pang Chan
    Mark Y. Chan
    Huay-Cheem Tan
    Nicholas W. S. Chew
    Poay Huan Loh
    Journal of Thrombosis and Thrombolysis, 2022, 53 : 671 - 682
  • [29] Comparison of biodegradable and newer generation durable polymer drug-eluting stents with short-term dual antiplatelet therapy: a systematic review and Bayesian network meta-analysis of randomized trials comprising of 43,875 patients
    Chong, Bryan
    Goh, Rachel Sze Jen
    Kong, Gwyneth
    Sim, Faith Ruo En
    Ng, Chen Han
    Teo, Xin Yi Vanessa
    Quek, Jing Xuan
    Lim, Oliver
    Chin, Yip Han
    Chan, Siew-Pang
    Chan, Mark Y.
    Tan, Huay-Cheem
    Chew, Nicholas W. S.
    Loh, Poay Huan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (03) : 671 - 682
  • [30] The Efficacy and Safety of P2Y12 Inhibitors After a Short Course of Three Months or Less of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention and Drug-Eluting Stent Placement: A Meta-Analysis
    Elzanaty, Ahmed
    Nazir, Salik
    Awad, Mohammed
    Eltahawy, Ehab
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S16 - S16
1234